Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 14 Apr 2025

5-methoxytryptophan ameliorates renal ischemia/reperfusion injury by alleviating endoplasmic reticulum stress-mediated apoptosis through the Nrf2/HO-1 pathway

in Renal Pharmacology

Shaona Li
Hongjuan Yang
Bing Zhang
Lingyu Li
Xiangkun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1506482

213 views

Original Research

Published on 09 Apr 2025

TRPC3 contributes to cyclophosphamide-induced cystitis progression by enhancing bladder fibrosis through activation of the TGF-β/smad pathway

in Renal Pharmacology

Ruixiang Luo
Wenshuang Li
Junlong Huang
Zheng Liu
Chi Zhang
Honglu Ding
Jialiang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565156

313 views

Original Research

Published on 08 Apr 2025

Vaccinium myrtillus L. ameliorates diabetic nephropathy via modulating metabolites and gut microbiota in rats

in Renal Pharmacology

Xinxin Cao
Fan Yao
Wenxiu Liu
Yufang Wang
Zhen Zhang
Chongyang Zhang
Zhengqi Dong
Bin Zhang
Ruikun He
Xiaobo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1541947

333 views

Review

Published on 08 Apr 2025

Overview of pharmacodynamical research of traditional Chinese medicine on hyperuricemic nephropathy: from the perspective of dual-regulatory effect on the intestines and kidneys

in Renal Pharmacology

Ting Wang
Li Li
Li Liu
Ruirong Tan
Qinxuan Wu
Xin Zhu
Hua Hua
Ying Dai
Huan Li
Jiuzhou Mao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1517047

301 views

Review

Accepted on 07 Apr 2025

An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease

in Renal Pharmacology

Anqi Feng
Ruili Yin
Rong Xu
Baoyu Zhang
Longyan Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559026

Mini Review

Accepted on 04 Apr 2025

Quantification of Endogenous and Therapeutic IgG Crossing the Kidney Barrier from Bloodstream to Urine

in Renal Pharmacology

Barbara Eicher
Christoph Esslinger
Matthias Hillenbrand

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572739

Original Research

Published on 04 Apr 2025

Landscape analysis of m6A modification regulators reveals LRPPRC as a key modulator in tubule cells for DKD: a multi-omics study

in Renal Pharmacology

Li Jiang
Hongda Yu
Jie Jian
Xulin Sai
Yudian Wang
Yufei Zhang
Xiai Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1506896

297 views

Original Research

Published on 04 Apr 2025

Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center

in Renal Pharmacology

Naama Lax
Miriam Davidovits
Gabriel Chodick
Yael Bernfeld
Orit Peled

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1535407

457 views

Original Research

Published on 04 Apr 2025

Endoplasmic reticulum stress aggravates ferroptosis via PERK/ATF4/HSPA5 pathway in UUO-induced renal fibrosis

in Renal Pharmacology

Zhigang Huang
Lihua Zhou
Bin Liu
Xiaoju Li
Yu Sang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545972

415 views

Review

Published on 01 Apr 2025

The molecular determinants regulating redox signaling in diabetic endothelial cells

in Renal Pharmacology

Swayam Prakash Srivastava
Olivia Kopasz-Gemmen
Aaron Thurman
Barani Kumar Rajendran
M. Masilamani Selvam
Sandeep Kumar
Rohit Srivastava
M. Xavier Suresh
Reena Kumari
Julie E. Goodwin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563047

449 views

Review

Accepted on 31 Mar 2025

Gut Microbiome Dynamics of Patients on Dialysis: Implications for Complications and Treatment

in Renal Pharmacology

Changlin Li
Xiaomeng Lin
Yuting Li
Jiamin Duan
Xudong Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1470232

Systematic Review

Published on 27 Mar 2025

Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials

in Renal Pharmacology

Jingyi Guo
Maoying Wei
Wenhua Zhang
Yijia Jiang
Aijing Li
Churan Wang
Dan Yin
Anning Sun
Yanbing Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1517272

2,316 views

Original Research

Published on 27 Mar 2025

Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database

in Renal Pharmacology

Pan Ding
Qinghua Luo
Leihua Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1511115

1,083 views

Correction

Published on 25 Mar 2025

Corrigendum: Population dynamics analysis of the interaction between tacrolimus and voriconazole in renal transplant recipients

in Renal Pharmacology

Zhi-Hua Sun
Yi-Chang Zhao
Jia-Kai Li
Fenghua Peng
Feng Yu
Bi-Kui Zhang
Miao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584520

482 views

Original Research

Published on 24 Mar 2025

Yiqi Qingre Gao alleviates renal fibrosis in UUO mice via PI3K/AKT pathway

in Renal Pharmacology

Qi Jin
Qian Li
Liping Yang
Fang Ma
Huimin Mao
Yuyang Wang
Tongtong Liu
Liang Peng
Ping Li
Yongli Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538061

555 views

Original Research

Accepted on 20 Mar 2025

HDAC3 inhibition mitigates acute kidney injury by alleviating RIPK1-mediated programmed necrosis

in Renal Pharmacology

Qi Chen
Manman Xie
Rui Hou
Runrun Shan
Xinyu Cheng
Pengcheng Wu
Xiufeng Luo
Yangyang Wei
Li Gao
Xiaoying Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546950